|
|
|
Volumn 24, Issue 2, 1997, Pages 90-96
|
|
Antiplatelet therapy with glycoprotein IIb/IIIa receptor inhibitors and other novel agents
|
|
Author keywords
Amino acid sequence; Antibodies; Cell surface; Fibrinogen; Monoclonal; Peptides therapeutic use; Platelet activation drug effects; Platelet aggregation inhibitors therapeutic use; Platelet glycoprotein GPIIb IIIa complex antagonists and inhibitors; Platelet membrane glycoproteins antagonists and inhibitors; Receptors; Thrombosis prevention and control
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
ARGINYLGLYCYLASPARTIC ACID;
CLOPIDOGREL;
FIBRINOGEN;
FIBRINOGEN RECEPTOR;
FIBRINOGEN RECEPTOR ANTAGONIST;
MONOCLONAL ANTIBODY;
TICLOPIDINE;
ARTERY THROMBOSIS;
ARTICLE;
BLEEDING;
CLINICAL TRIAL;
DRUG MECHANISM;
HUMAN;
NONHUMAN;
RECEPTOR BINDING;
THROMBOCYTE AGGREGATION INHIBITION;
ASPIRIN;
DIPYRIDAMOLE;
HEMORRHAGE;
HUMANS;
PLATELET ACTIVATION;
PLATELET AGGREGATION INHIBITORS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
THROMBOSIS;
TICLOPIDINE;
|
|
EID: 0031007286
PISSN: 07302347
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (11)
|
|
References (9)
|
